Picture of Hikma Pharmaceuticals logo

HIK Hikma Pharmaceuticals Share Price

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Momentum

Relative Strength (%)
1m-6.93%
3m+5.7%
6m-12.78%
1yr+7%
Volume Change (%)
10d/3m+22.96%
Price vs... (%)
52w High-13.79%
50d MA-0.93%
200d MA-1.24%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)11.51
PEG Ratio (f)n/a
EPS Growth (f)-15.56%
Dividend Yield (f)2.91%
Valuation (ttm)IndustryMarket
Price to Book Value2.44
Price to Tang. Book4.88
Price to Free Cashflow13.26
Price to Sales1.86
EV to EBITDA10.23

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital10.84%
Return on Equity8.77%
Operating Margin12.59%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m2,2032,3412,5532,5172,8752,952.133,067.286.73%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+13.41-30.77+11.04+22.29+28.42-21.02+7.91n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Hikma Pharmaceuticals EPS forecast chart

Profile Summary

Hikma Pharmaceuticals PLC is a pharmaceutical company. The principal activities of the Company are the development, manufacture and marketing of a range of generic, branded and in-licensed pharmaceutical products. The Company operates through three segments: Injectables, Branded and Generics. The Injectables segment supplies hospitals across its markets with generic injectable products, supported by its manufacturing facilities in the United States, Europe and Middle East/North Africa (MENA). The Branded segment supplies branded generics and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. The Generics segment supplies oral and other non-injectable generic and specialty products to the United States retail market, leveraging its manufacturing facility in Columbus, Ohio. Its subsidiaries include Al Jazeera Pharmaceutical Industry S.A.R.L, Hikma Pharma Algeria S.A.R.L. and others.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
September 8th, 2005
Public Since
November 1st, 2005
No. of Employees
8,967
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
221,885,259

HIK Share Price Performance

Upcoming Events for HIK

April 2024 Hikma Pharmaceuticals PLC Trading Statement Release

Hikma Pharmaceuticals PLC Annual Shareholders Meeting

Hikma Pharmaceuticals PLC Annual Shareholders Meeting

Half Year 2024 Hikma Pharmaceuticals PLC Earnings Release

Similar to HIK

Picture of Alliance Pharma logo

Alliance Pharma

gb flag iconLondon Stock Exchange

Picture of Animalcare logo

Animalcare

gb flag iconLondon Stock Exchange

Picture of AstraZeneca logo

AstraZeneca

gb flag iconLondon Stock Exchange

Picture of Beximco Pharmaceuticals logo

Beximco Pharmaceuticals

gb flag iconLondon Stock Exchange

Picture of BSF Enterprise logo

BSF Enterprise

gb flag iconLondon Stock Exchange

FAQ